Dose-finding Study to Assess the Efficacy, Safety and Tolerability of Tobramycin Inhalation Powder in Patients With Non-Cystic Fibrosis Bronchiectasis and Pulmonary P. Aeruginosa Infection

PHASE2CompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

February 8, 2017

Primary Completion Date

March 20, 2019

Study Completion Date

March 20, 2019

Conditions
Non-cystic Fibrosis Bronchiectasis
Interventions
DRUG

TIP

TIP dose regimen

DRUG

TIP and placebo

TIP and inhaled placebo dose regimen

DRUG

Placebo

Inhaled placebo dose regimen

Trial Locations (34)

1070

Novartis Investigative Site, Brussels

3000

Novartis Investigative Site, Leuven

14059

Novartis Investigative Site, Berlin

20112

Novartis Investigative Site, Milan

20900

Novartis Investigative Site, Monza

27100

Novartis Investigative Site, Pavia

30625

Novartis Investigative Site, Hanover

31059

Novartis Investigative Site, Toulouse

33170

Novartis Investigative Site, Pordenone

34059

Novartis Investigative Site, Montpellier

38043

Novartis Investigative Site, Grenoble

45239

Novartis Investigative Site, Essen

46009

Novartis Investigative Site, Valencia

46014

Novartis Investigative Site, Valencia

47003

Novartis Investigative Site, Valladolid

48903

Novartis Investigative Site, Baracaldo - Vizcaya

56124

Novartis Investigative Site, Pisa

60596

Novartis Investigative Site, Frankfurt

84018

Novartis Investigative Site, Scafati

06001

Novartis Investigative Site, Nice

04357

Novartis Investigative Site, Leipzig

08035

Novartis Investigative Site, Barcelona

08036

Novartis Investigative Site, Barcelona

08041

Novartis Investigative Site, Barcelona

08003

Novartis Investigative Site, Barcelona

CB23 3RE

Novartis Investigative Site, Cambridge

DD1 9SY

Novartis Investigative Site, Dundee

B15 2TH

Novartis Investigative Site, Birmingham

ED16 4SA

Novartis Investigative Site, Edinburgh

LA1 4RP

Novartis Investigative Site, Lancaster

LS9 7TF

Novartis Investigative Site, Leeds

SW 6NP

Novartis Investigative Site, London

NE7 7DN

Novartis Investigative Site, Newcastle upon Tyne

SO16 6YD

Novartis Investigative Site, Southampton

Sponsors
All Listed Sponsors
collaborator

Queen's University, Belfast

OTHER

collaborator

University Hospital, Antwerp

OTHER

collaborator

University of Milan

OTHER

collaborator

Fundacion Clinic per a la Recerca Biomédica

OTHER

collaborator

Erasmus Medical Center

OTHER

collaborator

Papworth Hospital NHS Foundation Trust

OTHER_GOV

collaborator

Royal Brompton & Harefield NHS Foundation Trust

OTHER

collaborator

University of Dundee

OTHER

collaborator

University of Edinburgh

OTHER

lead

Novartis Pharmaceuticals

INDUSTRY